Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-07-11 1:36 pm Sale | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | STATE STREET CORP STT | 3,930,917 5.94% | -2,547,905 (-39.33%) | View |
| 2022-05-09 5:15 pm Purchase | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | Redmile Group LLC | 5,680,917 8.1% | 5,016,100 (+754.51%) | View |
| 2022-02-14 6:35 pm Purchase | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | ARMISTICE CAPITAL LLC | 3,430,154 5.9% | 3,430,154 (New Position) | View |
| 2022-02-14 5:07 pm Sale | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | Redmile Group LLC | 664,817 1.1% | -3,773,151 (-85.02%) | View |
| 2022-02-11 4:10 pm Purchase | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | Flynn James E | 5,580,456 9.54% | 1,376,556 (+32.74%) | View |
| 2022-02-09 3:43 pm Sale | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | VANGUARD GROUP INC | 3,469,317 5.93% | -366,441 (-9.55%) | View |
| 2022-02-03 4:41 pm Purchase | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | BlackRock Inc. BLK | 3,797,569 6.5% | 387,711 (+11.37%) | View |
| 2022-02-03 1:46 pm Sale | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | FRANKLIN RESOURCES INC BEN | 5,339 0% | -3,581,500 (-99.85%) | View |
| 2022-02-02 1:03 pm Purchase | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | GOLDMAN SACHS GROUP INC GS | 3,623,245 6.2% | 3,623,245 (New Position) | View |
| 2022-01-31 1:16 pm Purchase | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | BANK OF AMERICA CORP BAC | 3,025,313 5.2% | 3,025,313 (New Position) | View |
| 2022-01-10 10:29 am Purchase | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | STATE STREET CORP STT | 6,478,822 11.08% | 6,478,822 (New Position) | View |
| 2021-11-10 4:59 pm Purchase | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | Flynn James E | 4,203,900 7.19% | 4,203,900 (New Position) | View |
| 2021-02-16 4:07 pm Sale | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | Redmile Group LLC | 4,437,968 7.8% | -271,530 (-5.77%) | View |
| 2021-02-10 10:46 am Purchase | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | VANGUARD GROUP INC | 3,835,758 6.74% | 3,835,758 (New Position) | View |
| 2021-02-02 3:13 pm Purchase | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | BlackRock Inc. BLK | 3,409,858 6% | 3,409,858 (New Position) | View |
| 2021-02-01 2:06 pm Purchase | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | FRANKLIN RESOURCES INC BEN | 3,586,839 6.3% | 3,586,839 (New Position) | View |
| 2020-02-14 5:05 pm Sale | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | ORBIMED ADVISORS LLC | 1,256,371 2.46% | -837,529 (-40.00%) | View |
| 2020-02-14 4:25 pm Purchase | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | Redmile Group LLC | 4,709,498 9.2% | 4,709,498 (New Position) | View |
| 2019-11-15 4:24 pm Sale | 13D | DECIPHERA PHARMACEUTICALS INC DCPH | New Leaf Ventures III L.P. | 2,421,655 4.7% | -1,682,485 (-40.99%) | View |
| 2019-10-22 5:13 pm Purchase | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | INTEGRATED CORE STRATEGIES (US) LLC | 2,508,584 4.95% | 57,935 (+2.36%) | View |